ArticleBioMedicine2023

Efficacy of HMJ-38, a new quinazolinone analogue, against the gemcitabine-resistant MIA-PaCa-2 pancreatic cancer cells.

Mann-Jen Hour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.